Acrux Limited (ASX:ACR) Receives FDA Approval for Nitroglycerin Ointment
Acrux Limited has received FDA approval for Nitroglycerin Ointment, expanding its portfolio in the topical market.
Acrux Limited has received FDA approval for Nitroglycerin Ointment, expanding its portfolio in the topical market.
Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall sell shares, reaffirming their commitment and retaining significant holdings.
Black Dragon Gold faces permitting delays as its land re-zoning application for the Salave Gold Project is rejected by local council.
4DMedical Limited announces a contract with Perth Radiological Clinic to enhance lung diagnostics using XV Technology across multiple clinics.
Athena Resources (ASX:AHN) announces a fully underwritten A$2.67 million entitlement offer to fund its Byro Magnetite Project.
Chorus Limited outlines its strategic reset and financial guidance during its Investor Day 2024.
Atturra Limited (ASX:ATA) has completed the acquisition of Plan B, enhancing its managed services and expanding its reach in New Zealand.
AnteoTech Ltd (ASX: ADO) announces vital commercial engagements in the expanding Indian healthcare market.
Micro-X Ltd is in advanced stages regarding a US$8.15 million development contract yet to receive full execution.
Streamplay Studio Limited (ASX:SP8) outlines operational successes and strategic acquisition plans to enhance its gaming portfolio.